Le Moniteur des pharmacies Pharmacien manager Porphyre PharmaVet Le Moniteur hospitalier Pharmagora


Le Moniteur hospitalier : Compléments

Le Moniteur Hospitalier

Bibliographie dossier (n°223): Psychoses pharmaco-induites

Quelques repères bibliographiques...

Ben Amar M., Potvin S. (2007)
Cannabis and psychosis: what is the link ?
J. Psychoactive Drugs, 39(2), pp.131-142.

Coulston C.M., Perdices M., Tennant C.C. (2007)
The neuropsychological correlates of cannabis use in schizophrenia : lifetime abuse / dependance, frequency of use, and recency of use.
Schizophr. Res., 96(1-3), pp.169-184.

Ellgren M., Artmann A., Tkalych O., Gupta A., Hansen H.S., Hansen S.H., Devi L.A., Hurd Y.L. (2008)
Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
Eur. Neuropsychopharmacol., 18(11), pp.826-834.

Freedman et al. (2008).
Cannabis, inhibitory neurons, and the progressive course of schizophrenia.
Am. J. Psychiatry, 165, pp.416-419.

Gilbert G.L., Kim H.J., Waataja J.J., Thayer S.A. (2007)
Delta-9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity.
Brain Res., 1128(1), pp.61-69.

Gonzalez-Pinto A, Vega P, Ibanez B, Mosquera F, Barbeito S, Gutierrez M, et al. (2008)
Impact of cannabis and other drugs on age at onset of psychosis.
J. Clin. Psychiatry. 69(8), pp.1210-1216.

Hall W., Degenhardt L. (2008)
Cannabis use and the risk of developing a psychotic disorder.
World Psychiatry, 7(2), pp.68-71.

Keshavan M.S., Tandon R., Boutros N.N., Nasrallah H.A. (2008)
Schizophrenia, "just the facts": what we know in 2008 (neurobiology).
Schiz. Res., 106, pp.89-107.

Laqueille X., Launay C., Kanit M. (2008)
Les troubles psychiatriques et somatiques induits par le cannabis.
Ann. Pharm. Fr., 66(4), pp.245-254.

Miettunen J., Törmänen S., Murray G.K. et al. (2008)
Association of cannabis use with prodromal symptoms of psychosis in adolescence.
Br. Journal of Psychiatry, 192 pp.470-471.

Moore T.H., Zammit S, Lingford-Hughes A, Barnes T.R., Jones P.B., Burke M, Lewis G. (2007)
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Lancet, 28;370(9584), pp.319-328

Palmer R.H., Young S.E., Hopfer C.J. et al. (2009)
Developmental epidemiology of drug use and abuse in adolescence and young adulthood: evidence of generalized risk.
Drug Alcohol Depend., 26 (publication électronique).

Rathbone J., Variend H., Mehta H. and the Cochrane Schizophrenia Group (2009)
Cannabis and schizophrenia (review).
Cochrane database Syst. Rev., 16(3), 31 pages.

Yücel M., Lubman D.I., Solowii N., Brewer W.J. (2007)
Understanding drug addiction: a neuropsychological perspectives.
Aus. N.Z. Psychiatry, 41(12), pp.957-968.

Yücel M., Solowii N., Respondek C., Whittle S., Fornito A., Pantelis C., Lubman D.I. (2008)
Regional abnormalities associated with long-term heavy cannabis use.
Arch. Gen. Psychiatry, 65(6), pp.694-701.

Zammit S., Moore T.H., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. (2008)
Effects of cannabis use on outcomes of psychotic disorders: systematic review.
Br. J. Psychiatry, 193(5), pp.357-363.



    (Publicité)

Nouveautés


Guide du management à l'officine



En savoir +

Forums

Exprimez-vous et échangez avec vos confrères sur les forums

Newsletter

La Lettre d'info du Moniteur des pharmacies, l'essentiel de l'actualité et des informations utiles à l'officine.

Restez connecté

Le Moniteur des pharmaciesFacebook Le Moniteur des pharmacies
Pharmacien manager Facebook Le Moniteur des pharmacies
Porphyre Facebook Le Moniteur des pharmacies